Iodide

Iodide

SCHEMBL5247675

CC[N+]1=C(C)C(C)(C)c2cc(Cl)ccc21.[I-]

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.71
MEN1 O00255 1/20 0.71
MAPT P10636 1/20 0.71
THRB P10828 1/20 0.71
HTT P42858 1/20 0.71
RECQL P46063 1/20 0.71
KMT2A Q03164 1/20 0.71
TDP1 Q9NUW8 1/20 0.71
PRMT1 Q99873 1/20 0.33
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12453354 0.79 MEN1 (0.69) LMNAMEN1MAPTTHRBHTT
Iodide SCHEMBL3852244 0.78 MAPT (0.68) LMNAMEN1MAPTTHRBHTT
Iodide SCHEMBL6832522 0.78 MEN1 (0.42) LMNAMEN1MAPTTHRBHTT
SCHEMBL16867351 0.76 MEN1 (0.65) LMNAMEN1MAPTTHRBHTT
SCHEMBL4617512 0.76 MAPT (0.65) LMNAMEN1MAPTTHRBHTT
SCHEMBL3961483 0.76 TDP1 (0.40) LMNAMEN1MAPTTHRBHTT
Iodide SCHEMBL2320529 0.76 MAPT (0.65) LMNAMEN1MAPTTHRBHTT
Iodide SCHEMBL29658781 0.76 MAPT (0.65) LMNAMEN1MAPTTHRBHTT
Bromide SCHEMBL4615096 0.75 MAPT (0.63) LMNAMEN1MAPTTHRBHTT
SCHEMBL41357 0.75 LMNA (0.63) LMNAMEN1MAPTTHRBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1223196-B1 Negative image-recording material and cyanine dye FUJIFILM CORP (JP) 2007-09-12 EP disclosed
US-6797449-B2 FOR PLANOGRAPHIC PRINTING PLATE PRECURSORS, COLOR PROOFS, PHOTORESISTS AND COLOR FILTERS; HIGH INFRARED RADIATION ABSORPTION; SEMICONDUCTOR LASERS FUJI PHOTO FILM CO., LTD. (JP) 2004-09-28 US disclosed
US-20030022094-A1 For planographic printing plate precursors, color proofs, photoresists and color filters; high infrared radiation absorption; semiconductor lasers FUJIFILM CORPORATION (JP) 2003-01-30 US disclosed
EP-1223196-A2 Negative image-recording material and cyanine dye Fuji Photo Film Co., Ltd. (JP) 2002-07-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030022094-A1 For planographic printing plate precursors, color proofs, photoresists and color filters; high infrared radiation absorption; semiconductor lasers MARK4, MARK3, IK LMNA 3401/4885MEN1 3630/4885MAPT 995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.